⌘K

Home/Filings/4/0000899866-21-000023

4//SEC Filing

ORLOFF JOHN J 4

Accession 0000899866-21-000023

CIK 0000899866other

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 5:50 PM ET

Size

4.8 KB

Accession

0000899866-21-000023

Insider Transaction Report

Form 4

Period: 2021-02-28

ALEXION PHARMACEUTICALS, INC.ALXN

EVP, Research & Development

Transactions

Award
Common Stock, par value $.0001 per share
2021-02-28+24,473→ 88,324 total

Footnotes (1)

[F1]Award of Restricted Stock Units under the 2017 Incentive Plan. 25% vests on each anniversary of the grant date.

Documents

1 file

4
wf-form4_161472540804716.xmlPrimary
FORM 4

Issuer

ALEXION PHARMACEUTICALS, INC.

CIK 0000899866

Entity typeother

Related Parties

1

filerCIK 0001643941

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 5:50 PM ET
Size: 4.8 KB

View on SEC.gov